423 related articles for article (PubMed ID: 27094559)
21. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
24. High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?
Wei L; Bai L; Zhao L; Yu T; Ma Q; Ji B
World J Surg; 2019 May; 43(5):1256-1263. PubMed ID: 30684002
[TBL] [Abstract][Full Text] [Related]
25. Long-term Outcomes of cN0 Papillary Thyroid Carcinoma without Elective Central Compartment Neck Dissection.
Zhou B; Huang H; Xu Z; Wu Y; Wang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Jun; 39(3):383-388. PubMed ID: 28695810
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma.
Hu D; Zhou J; He W; Peng J; Cao Y; Ren H; Mao Y; Dou Y; Xiong W; Xiao Q; Su X
World J Surg Oncol; 2018 Feb; 16(1):30. PubMed ID: 29439716
[TBL] [Abstract][Full Text] [Related]
27. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.
Popadich A; Levin O; Lee JC; Smooke-Praw S; Ro K; Fazel M; Arora A; Tolley NS; Palazzo F; Learoyd DL; Sidhu S; Delbridge L; Sywak M; Yeh MW
Surgery; 2011 Dec; 150(6):1048-57. PubMed ID: 22136820
[TBL] [Abstract][Full Text] [Related]
28. The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study.
Noda S; Onoda N; Morisaki T; Kashiwagi S; Takashima T; Hirakawa K
Int J Surg; 2015 Aug; 20():52-7. PubMed ID: 26079502
[TBL] [Abstract][Full Text] [Related]
29. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
30. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
31. Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
Chu KP; Baker S; Zenke J; Morad A; Ghosh S; Morrish DW; McEwan AJBS; Williams DC; Severin D; McMullen TPW
Thyroid; 2018 Jul; 28(7):902-912. PubMed ID: 29742993
[TBL] [Abstract][Full Text] [Related]
32. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy.
Lang BH; Ng SH; Lau LL; Cowling BJ; Wong KP; Wan KY
Thyroid; 2013 Sep; 23(9):1087-98. PubMed ID: 23402640
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
34. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for non-small-volume central lymph node metastases (more than 5 or ≥ 2 mm) in clinically node-negative papillary thyroid carcinoma.
Wang JB; Sun YY; Shi LH; Xie L
Medicine (Baltimore); 2019 Jan; 98(1):e14028. PubMed ID: 30608456
[TBL] [Abstract][Full Text] [Related]
36. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of Endocrine Surgery) multicentre study based on the EUROCRINE® national data.
Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
[TBL] [Abstract][Full Text] [Related]
37. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China.
Xue S; Wang P; Liu J; Li R; Zhang L; Chen G
Asian J Surg; 2016 Jul; 39(3):131-6. PubMed ID: 26117203
[TBL] [Abstract][Full Text] [Related]
39. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
[TBL] [Abstract][Full Text] [Related]
40. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
